NCT06183242View on ClinicalTrials.gov

Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

328

Participants

Timeline

Start Date

May 27, 2023

Primary Completion Date

September 24, 2024

Study Completion Date

October 10, 2024

Conditions

Cholestasis, Intrahepatic

Interventions

DRUG

Remaxa, enteric-coated tablets

enteric-coated tablets

DRUG

Remaxol

solution for infusions

DRUG

Placebo

enteric-coated tablets

Trial Locations (3)

196143

Research Center for Eco-safety, Ltd., Saint Petersburg

197706

City Hospital of the Holy Martyr Elizabeth, Saint Petersburg

443063

"Medical Company Hepatologist Ltd.", Samara

All Listed Sponsors

lead

POLYSAN Scientific & Technological Pharmaceutical Company

INDUSTRY

NCT06183242 - Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis | Biotech Hunter | Biotech Hunter